Auro-Metformin 500 mg Tablet is a Health Canada–registered human drug (DIN 02438275) held by Auro Pharma Inc, containing Metformin Hydrochloride. Health Canada lists its status as Marketed (status date 22 Feb 2017). Nexara Health has matched 2288 registrations of Metformin Hydrochloride across 38 other regulated markets, 120 of them in the same strength and dosage form.

Health Canada registration

Metformin Hydrochloride registered in other markets

2288 registrations of the same molecule in 38 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Metformin Hydrochloride worldwide →

Regulator price references for Metformin Hydrochloride

Published list or reimbursement prices for Metformin Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Related molecules (ATC A10BA)

• Metformin Hydrochloride

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Auro-Metformin (DIN 02438275) marketed in Canada?

Yes. Health Canada lists DIN 02438275 as Marketed as of 22 Feb 2017.

Who holds the Canadian licence for this product?

Auro Pharma Inc is the company of record in the Health Canada Drug Product Database.

Is Metformin Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 2288 registrations in 38 other markets, including 120 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02438275, status date 2017-02-22; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Medicines Authority, MZ SR kategorizacia, NHRA, PBS, SFDA, SUKL DLP, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02438275, status date 2017-02-22; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Medicines Authority, MZ SR kategorizacia, NHRA, PBS, SFDA, SUKL DLP, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), NHRA, PBS.

Health Canada Drug Product Database (DPD), DIN 02438275, status date 2017-02-22; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Medicines Authority, MZ SR kategorizacia, NHRA, PBS, SFDA, SUKL DLP, URPL RPL; price sources: EDE, eEKO (Erstattungskodex), NHRA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.